Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02589873 · ClinicalTrials.gov registry record · NA

Getting in Balance: A Workplace Diabetes Prevention Intervention Trial

A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
157
Enrollment target
1
Study location

NCT02589873 is a NA study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by Kaiser Permanente. The registered enrollment target is 157 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02589873, a NA study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
157 participants
Enrollment target
1
Study location

Study Summary

This study evaluates two group-based Diabetes Prevention Program (DPP) lifestyle interventions delivered in the workplace to individuals at risk for pre-diabetes: 1) an in-person group-based lifestyle intervention; and 2) an internet-based intervention delivered using an online platform with lifestyle coaching support. Eligible participants will be randomized equally to each intervention program (120 participants in each).

Interventions

  • BEHAVIORAL In-Person Diabetes Prevention Program
  • BEHAVIORAL Online Diabetes Prevention Program

Study Locations (1)

California

  • City and County of San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 157 participants
Start Date 2015-09
Est. Completion 2017-08-15
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT02589873

The ClinicalTrials.gov registry entry for NCT02589873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (81% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which In-Person Diabetes Prevention Program is the first listed.

NCT02589873 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02589873 about?

NCT02589873 is a clinical study titled "Getting in Balance: A Workplace Diabetes Prevention Intervention Trial". This study evaluates two group-based Diabetes Prevention Program (DPP) lifestyle interventions delivered in the workplace to individuals at risk for pre-diabetes: 1) an in-person group-based lifestyle intervention; and 2) an internet-based intervention delivered using an online platform with lifesty...

What is the current status of trial NCT02589873?

This trial is currently completed. It is a NA study. The enrollment target is 157 participants. The study started on 2015-09. Estimated completion is 2017-08-15.

What conditions does trial NCT02589873 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2, Overweight.

What interventions are being tested in trial NCT02589873?

The interventions under investigation include: In-Person Diabetes Prevention Program (BEHAVIORAL), Online Diabetes Prevention Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02589873?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02589873 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.